An overview of hypoxia-induced oxidative stress and NRF2 role in breast cancer progression
DYSONA – Life Science · 01.10.2023 · 4 (2) · 50
DOI: 10.30493/dls.2023.413087 ↗Kurz gefasst
Fachartikel in der Zeitschrift DYSONA – Life Science, online erschienen am 01.10.2023. Verfasst von Megharani Mahajan. Die Arbeit nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite the significant progress made in the areas of early detection, treatment, and neoadjuvant therapy, breast cancer remains a prominent cause of mortality on a global scale. The tumor microenvironment (TME) is of paramount importance in the context of therapeutic resistance and the advancement of cancer. Hypoxia, characterized by a low level of oxygen, is a prevalent attribute found in the majority of TME. Hypoxia induces the production of reactive oxygen species (ROS), leading to the occurrence of oxidative stress. The occurrence of hypoxia-induced oxidative stress results in the modification of cancer cell metabolism, impaired vascularization, enhanced cell motility, and metastasis, ultimately resulting in the acquisition of epithelial-to-mesenchymal transition (EMT). Hence, the presence of hypoxia-induced oxidative stress poses a substantial obstacle to the successful implementation of cancer therapies. Hypoxia-inducible factor-1α (HIF-1α) plays a pivotal role in the cellular response to hypoxia in tumors. It initiates the transcription of a multitude of genes, encompassing pro-angiogenic and pro-metastatic genes. Another significant signaling molecule that is activated in response to tumor hypoxia and oxidative stress is nuclear factor erythroid 2–related factor 2 (Nrf2). The regulatory role of ROS encompasses the modulation of both HIF-1α and Nrf2 signaling pathways. Moreover, the essentiality of coordinated signaling between HIF-1α and Nrf2 for tumor survival, metastasis, and chemo-resistance is evident, thereby contributing to the progression of tumors. While HIF-1α is widely recognized as a crucial mediator of the cellular reaction to low oxygen levels, it is important to note that Nrf2, a transcription factor responsible for regulating antioxidants, plays a critical role in facilitating HIF-1α-mediated responses to hypoxia. This review article places emphasis on the role of hypoxia-induced oxidative stress in the progression of breast cancer, discussing the underlying mechanisms associated with this phenomenon.
Zitieren
APA
Mahajan, M. (2023). An overview of hypoxia-induced oxidative stress and NRF2 role in breast cancer progression. DYSONA – Life Science, 4(2), 50. https://doi.org/10.30493/dls.2023.413087
Vancouver
Mahajan M. An overview of hypoxia-induced oxidative stress and NRF2 role in breast cancer progression. DYSONA – Life Science. 2023;4(2):50. doi:10.30493/dls.2023.413087
BibTeX
@article{Mahajan2023,
author = {Mahajan, Megharani},
title = {An overview of hypoxia-induced oxidative stress and NRF2 role in breast cancer progression},
journal = {DYSONA – Life Science},
year = {2023},
volume = {4},
number = {2},
pages = {50},
doi = {10.30493/dls.2023.413087}
}
EUVIMED